Dr William Deegan recently spoke to the National Capital Region Federal Optometric Society (NCRFOS) on Friday April 8 at the Navy Yards. The NCRFOS represents active duty optometrists in the National Capital Region. He spoke on Pediatric Retinal Diseases and Systemic Cancer and the Eye.
To learn more about Pediatric Retinal Diseases and Systemic Cancer and the Eye click here.
Modernizing Medicine, Inc., the creator of the Electronic Medical Assistant® (EMA™), a cloud-based, iPad native, specialty-specific electronic medical record (EMR) system, announced today that The Retina Group of Washington has selected EMA Ophthalmology to replace its legacy EMR solution. Use of the highly specialized EMR system will help streamline physician workflows and improve patient care across the entire practice.
With 26 physicians working across 14 offices, The Retina Group of Washington is one of the largest and most highly respected retinal and macular practices in the country. The Retina Group of Washington is well known for its extensive experience and sub-specialty expertise of its leading physicians and surgeons. Deeply committed to the advancement of care, the group is constantly conducting cutting-edge research and administers a Fellowship program to train future ophthalmologists.
“As one of the leading retinal practices in the country, we constantly look for ways to make our physicians’ lives easier and improve care,” said Dr. Michael Rivers, current Board member at The Retina Group of Washington and head of their EMR system selection committee.
Dr William Deegan gave Anesthesia Grand Rounds at Virginia Hospital Center and discussed “Plaque Brachytherapy for Intraocular Tumors”
For more information on Plaque Brachytherapy click here.
Dr William Deegan gave 2 lectures to the Virginia Society of Peri-Anesthesia Nurses meeting. He discussed “Diagnosis and Management of Adult and Pediatric Retinal Detachment” and “Diagnosis and Treatment of Retinoblastoma”
For more information on Retinoblastoma click here.
For more information on Retinal Detachment click here.
Drs. Reginald J. Sanders and William F. Deegan were selected by their colleagues in the medical field as “Top Doctors” in Ophthalmology as part of the 2015 “Top Doctors” published in the September issue of Washingtonian. The bi-annual survey, conducted for the first time online, solicited nominations from more than 12,000 physicians throughout D.C., Maryland and Virginia. The list is designed to help readers find the best medical care in their communities, including primary care doctors and those specialists whom patients choose for themselves.
Melamud A1, Pham H2, Stoumbos Z2.
To examine the visual outcomes of early intervention in the setting of fundus-obscuring vitreous hemorrhage (VH) presumed to be due to posterior vitreous detachment.
Retrospective comparative case series.
All eyes that presented with a fundus-obscuring VH defined as vision of 20/400 or worse, and requiring a B-scan at presentation from 2003 – 2013, were evaluated. Eyes with any history of retinopathy; macular degeneration; recent trauma; presentation greater than two weeks after onset of symptoms; or follow-up of less than two months were excluded. The main outcome measure studied was final best-correct visual acuity (BCVA) as dependent on the time to surgery.
92 eyes met inclusion criteria with a mean follow-up of 490 days. Initial BCVA was logMAR 2.218 (Snellen equivalent 20/3000-20/4000 range 20/400- light perception); final BCVA was 0.318 (Snellen equivalent of 20/40-20/50 range 20/20 – light perception, p < 0.001). 56 patients (60.8%) had either a retinal tear or a retinal detachment. Patients who underwent surgery within 1 week had no significant improvement over all others, however a significant improvement was found when comparing early versus delayed surgery groups (p<0.05). There was a significantly increased risk of developing a macula-off retinal detachment in patients who did not undergo surgery within one week of presentation.
Early surgical intervention results in similar visual outcomes compared to a conservative approach. However, early intervention significantly reduces the incidence of severe vision loss related to macula
involving retinal detachment. This study highlights the importance of close follow-up given the high risk of retinal detachment in fundus-obscuring vitreous hemorrhage.
Am J Ophthalmol.
2015 Jul 21. pii: S0002-9394(15)00449-3. doi: 10.1016/j.ajo.2015.07.025. [Epub ahead of print]
The management of retinal vein occlusion (RVO) has changed dramatically over the last 3 decades since the results of the Branch Vein Occlusion Study (BVOS) and Central Vein Occlusion Study (CVOS) were published in the 1980s and 1990s.
While most patients who present with RVO are 60 years of age or older, young patients can pose particular diagnostic and treatment challenges.
In this installment of Practical Retina, current RGW retina fellow Dr. Luke Lindsell and Dr. Michael Lai from Washington, D.C., address what should be included in an appropriate diagnostic work-up for younger patients who present with RVO, provide pearls for detecting uncommon underlying systemic etiologies, and review their treatment paradigm.
You can read about it in their article entitled “Current concepts in managing retinal vein occlusion in young patients” for the July/August 2015 issue of the journal Ophthalmic Surgery Lasers & Imaging Retina.
Click here to read more.
Source: Ophthalmic Surgery, Lasers and Imaging Retina July 2015 – Volume 46 · Issue 7: 695-701
Below is an excerpt from the article quoting Dr. Johnson as a consulting retinal surgeon. Click on the link below to read the full article:
Dr Silva noted, however, that the cost of ultrawide field imaging devices at the present time “is prohibitive,” especially in places with small populations and a limited number of diabetes patients. But prices will come down in time, he added.
Asked to comment, T Mark Johnson, MD, FRCSC, an attending surgeon at the Retina Group of Washington, DC, who was not involved in the study, agreed that the current costs of the cameras used in ultrawide field imaging, are “significant” and could therefore limit their use in screening programs.
And he claims that past studies have suggested that even three-field photography (just taking photos of the posterior pole of the retina) may be as good as ultrawide field imaging for screening for significant diabetic retinopathy. Therefore, more research is needed to justify the added costs of ultrawide field imaging, he pointed out.
See more: http://www.medscape.com/viewarticle/846470